Fairfield Financial Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-80
Closed -$1.48K 335
2022
Q4
$1.48K Hold
80
﹤0.01% 282
2022
Q3
$2.16K Hold
80
﹤0.01% 286
2022
Q2
$1.11K Buy
+80
New +$1.11K ﹤0.01% 283